Search results

The Chief Executive of University Hospitals Bristol and Weston NHS Foundation Trust, Eugine Yafele, has been appointed as a new Board member of the NHS Race and Health Observatory. Eugine will ensure a continued focus on acute delivery as the previous acute expert Board member Patricia Miller has taken on a new role.

Low immunisations, high Covid-19 rates and increased breast cancer risks – some of several health inequalities disproportionally found amongst Jewish communities in England – are set to be explored in new review commissioned by the NHS Race and Health Observatory.

The NHS Race and Health Observatory is calling for the development of a central data repository to map improvements around reducing poor outcomes in maternal and neonatal healthcare for Black, Asian and ethnic minority women.

Public health will not work without the public’s trust. Unfortunately, there is a loss of trust in public institutions among some in our ethnic minority communities.

Experimental statistics, published by the ONS, suggest that ethnic minority people have longer life expectancies than White people. In this blog NHS Race and Health Observatory board member, Professor James Nazroo and colleagues examine the nature of these statistics and why they should be treated with caution.

COVID-19 has painfully exposed the devastating impact inequalities in our society can have. With the benefit of hindsight, we cannot afford to leave our ethnic minorities communities behind this winter. Dr Halima Begum, CEO of the Runnymede Trust, on the case for door-to-door vaccination units.

General interventions and medications such as hydroxyurea, morphine and blood transfusions were hit and miss, usually giving relief for a period but the sickling would return with vengeance.

I came to the UK when my family moved from Kenya in 1968. It was a time when racism was overt in society, with signage in windows of flats to let openly stating “no blacks” and racial attacks such as “paki-bashing” were commonplace.

Wider genetic testing could save lives, reduce costs and help thousands of Black, Asian and ethnic minority patients at risk of severe side effects resulting from chemotherapy drugs.

The under-representation of ethnic minority communities taking part in research, along with the lack of systematic data collection and reporting, will be investigated by national health and care research stakeholders.